Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Br Poult Sci ; 60(6): 675-682, 2019 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-31321996

RESUMEN

1. The real burden of Campylobacter spp. in Lebanon is still unknown. The aims of this study were to unravel the epidemiology of Campylobacter spp. in broilers at slaughterhouses in Tripoli, North of Lebanon and to characterise their antibiotic resistance profiles.2. From May to November 2015, sampling was performed through five repeated surveys from 15 slaughterhouses that sold chicken directly to Lebanese customers. Isolates were subjected to pulsed field gel electrophoresis (PFGE) and flaA-restriction fragment length polymorphism (flaA-RFLP).3. All investigated slaughterhouses were found to be positive for Campylobacter spp. Campylobacter coli was the predominant species (38 isolates) followed by C. jejuni (eight isolates). A noticeable level of resistance was detected among isolates against ciprofloxacin (97% of C. coli and 87.5% of C. jejuni), amoxicillin (89% of C. coli and 75% of C. jejuni), gentamicin (79% of C. coli and 50% of C. jejuni), and co-amoxiclav (24% of C. coli and 25% of C. jejuni). Erythromycin and ertapenem resistance were observed only in C. coli with the following percentages 74% and 13% respectively, but not in C. jejuni. PFGE and flaA-RFLP using DdeI as restriction enzyme divided the strains into 27 and 25 types respectively.4. The high observed genetic diversity of Campylobacter spp. revealed the complexity of the spread of this genus in broilers. This study highlighted the pressing need to monitor antibiotic resistance and to ensure food safety from 'farm to fork' in Lebanon.


Asunto(s)
Infecciones por Campylobacter/veterinaria , Campylobacter/efectos de los fármacos , Pollos/microbiología , Enfermedades de las Aves de Corral/epidemiología , Mataderos , Animales , Antibacterianos/farmacología , Campylobacter/clasificación , Campylobacter/genética , Infecciones por Campylobacter/epidemiología , Infecciones por Campylobacter/microbiología , Ciego/microbiología , Farmacorresistencia Bacteriana , Electroforesis en Gel de Campo Pulsado/veterinaria , Flagelina/genética , Enfermedades Transmitidas por los Alimentos/epidemiología , Enfermedades Transmitidas por los Alimentos/microbiología , Variación Genética , Humanos , Líbano/epidemiología , Reacción en Cadena de la Polimerasa/veterinaria , Polimorfismo de Longitud del Fragmento de Restricción , Enfermedades de las Aves de Corral/microbiología , Prevalencia , Espectrometría de Masa por Láser de Matriz Asistida de Ionización Desorción/veterinaria
2.
Probiotics Antimicrob Proteins ; 6(3-4): 177-85, 2014 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-24880436

RESUMEN

Emerging resistance to antiviral agents is a growing public health concern worldwide as it was reported for respiratory, sexually transmitted and enteric viruses. Therefore, there is a growing demand for new, unconventional antiviral agents which may serve as an alternative to the currently used drugs. Meanwhile, published literature continues shedding the light on the potency of lactic acid bacteria (LAB) and their bacteriocins as antiviral agents. Health-promoting LAB probiotics may exert their antiviral activity by (1) direct probiotic-virus interaction; (2) production of antiviral inhibitory metabolites; and/or (3) via stimulation of the immune system. The aim of this review was to highlight the antiviral activity of LAB and substances they produce with antiviral activity.


Asunto(s)
Antivirales/administración & dosificación , Bacteriocinas/inmunología , Lactobacillaceae/inmunología , Probióticos/administración & dosificación , Virosis/tratamiento farmacológico , Animales , Humanos , Lactobacillaceae/genética , Virosis/inmunología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA